Residual SARS-CoV-2 RNA in nasal swabs of convalescent COVID-19 patients: Is prolonged quarantine always justified?


Journal

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
ISSN: 1878-3511
Titre abrégé: Int J Infect Dis
Pays: Canada
ID NLM: 9610933

Informations de publication

Date de publication:
Jan 2021
Historique:
received: 21 09 2020
revised: 21 10 2020
accepted: 23 10 2020
pubmed: 2 11 2020
medline: 20 1 2021
entrez: 1 11 2020
Statut: ppublish

Résumé

Real-time reverse transcription PCR is currently the most sensitive method to detect severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Defining whether a patient could be contagious or not contagious in the presence of residual SARS-CoV-2 RNA is of extreme importance in the context of public health. In this prospective multicenter study, virus isolation was prospectively attempted in 387 nasal swabs from clinically recovered patients showing low viral load (quantification cycle, Cq, value greater than 30). The median Cq value was 36.8 (range 30.0-39.4). Overall, a cytopathic effect was detected in nine samples, corresponding to a culture positivity rate of 2.3% (9/387). The results of this study help to dissect true virus replication and residual viral RNA detection in recovered patients.

Identifiants

pubmed: 33130202
pii: S1201-9712(20)32278-5
doi: 10.1016/j.ijid.2020.10.072
pmc: PMC7834568
pii:
doi:

Substances chimiques

RNA, Viral 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

299-302

Informations de copyright

Copyright © 2020 The Authors. Published by Elsevier Ltd.. All rights reserved.

Références

Emerg Infect Dis. 2020 Oct;26(10):2353-2360
pubmed: 32723432
Clin Chem. 2009 Apr;55(4):611-22
pubmed: 19246619
Euro Surveill. 2020 Jan;25(3):
pubmed: 31992387
Nature. 2020 May;581(7809):465-469
pubmed: 32235945
Lancet. 2020 Apr 25;395(10233):1339-1340
pubmed: 32304647
JAMA Netw Open. 2020 May 1;3(5):e209759
pubmed: 32442288
Eur J Clin Microbiol Infect Dis. 2020 Jun;39(6):1059-1061
pubmed: 32342252
JAMA. 2020 May 12;323(18):1843-1844
pubmed: 32159775
J Clin Microbiol. 2020 Jul 23;58(8):
pubmed: 32518072
Euro Surveill. 2020 Aug;25(32):
pubmed: 32794447

Auteurs

Antonio Piralla (A)

Molecular Virology Unit, Microbiology and Virology Department, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.

Matteo Ricchi (M)

Diagnostic Section of Piacenza, Istituto Zooprofilattico Sperimentale della Lombardia e dell'Emilia Romagna, (IZSLER), Piacenza, Italy.

Maria Grazia Cusi (MG)

Microbiology and Virology Unit, S. Maria delle Scotte University Hospital of Siena, Siena, Italy; Virology Unit, Department of Medical Biotechnologies, University of Siena, Siena, Italy.

Paola Prati (P)

Diagnostic Section of Pavia, Istituto Zooprofilattico Sperimentale della Lombardia e dell'Emilia Romagna (IZSLER), Pavia, Italy.

Nadia Vicari (N)

Diagnostic Section of Pavia, Istituto Zooprofilattico Sperimentale della Lombardia e dell'Emilia Romagna (IZSLER), Pavia, Italy.

Giada Scarsi (G)

Diagnostic Section of Pavia, Istituto Zooprofilattico Sperimentale della Lombardia e dell'Emilia Romagna (IZSLER), Pavia, Italy.

Claudia Gandolfo (C)

Microbiology and Virology Unit, S. Maria delle Scotte University Hospital of Siena, Siena, Italy; Virology Unit, Department of Medical Biotechnologies, University of Siena, Siena, Italy.

Gabriele Anichini (G)

Virology Unit, Department of Medical Biotechnologies, University of Siena, Siena, Italy.

Chiara Terrosi (C)

Virology Unit, Department of Medical Biotechnologies, University of Siena, Siena, Italy.

Elena Percivalle (E)

Molecular Virology Unit, Microbiology and Virology Department, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.

Edoardo Vecchio Nepita (E)

Molecular Virology Unit, Microbiology and Virology Department, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.

Federica Bergami (F)

Molecular Virology Unit, Microbiology and Virology Department, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.

Monica Tallarita (M)

Molecular Virology Unit, Microbiology and Virology Department, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.

Raffaella Di Martino (R)

Molecular Virology Unit, Microbiology and Virology Department, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.

Alessandro Ferrari (A)

Molecular Virology Unit, Microbiology and Virology Department, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.

Francesca Rovida (F)

Molecular Virology Unit, Microbiology and Virology Department, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.

Giovanna Lunghi (G)

Virology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.

Roberta Schiavo (R)

Microbiology Unit, Clinical Pathology Department, Guglielmo da Saliceto Hospital, Piacenza, Italy.

Fausto Baldanti (F)

Molecular Virology Unit, Microbiology and Virology Department, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy; Department of Clinical, Surgical, Diagnostic and Pediatric Sciences, University of Pavia, Pavia, Italy. Electronic address: f.baldanti@smatteo.pv.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH